These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 22607214)
1. Clinical utility of natriuretic peptides in dialysis patients. Wang AY Semin Dial; 2012 May; 25(3):326-33. PubMed ID: 22607214 [TBL] [Abstract][Full Text] [Related]
2. [Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure]. Bertinchant JP Arch Mal Coeur Vaiss; 2004 Sep; 97(9):881-8. PubMed ID: 15521481 [TBL] [Abstract][Full Text] [Related]
3. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients. Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients. Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403 [TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence. Dhar S; Pressman GS; Subramanian S; Kaul S; Gollamudi S; Bloom EJ; Figueredo VM Postgrad Med J; 2009 Jun; 85(1004):299-302. PubMed ID: 19528304 [TBL] [Abstract][Full Text] [Related]
6. The diagnostic utility of cardiac biomarkers in dialysis patients. Wang AY; Wai-Kei Lam C Semin Dial; 2012 Jul; 25(4):388-96. PubMed ID: 22748194 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E; J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211 [TBL] [Abstract][Full Text] [Related]
17. Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T. Sommerer C; Giannitsis E; Schwenger V; Zeier M Nephron Clin Pract; 2007; 107(3):c77-81. PubMed ID: 17890874 [TBL] [Abstract][Full Text] [Related]
18. Comparison of B-type natriuretic peptide and NT proBNP as predictors of survival in patients on high-flux hemodialysis and hemodiafiltration. Sivalingam M; Suresh M; Farrington K Hemodial Int; 2011 Jul; 15(3):359-65. PubMed ID: 21624043 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic, prognostic, and therapeutic implications of brain natriuretic peptide in dialysis and nondialysis-dependent chronic renal failure. Mark PB; Petrie CJ; Jardine AG Semin Dial; 2007; 20(1):40-9. PubMed ID: 17244121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]